About Melio
Melio is a company based in Santa Clara (United States) founded in 2018 by Shelley Lawrence, Stephanie Fraley, and Mridu Sinha. It operates as a HealthTech. Melio has raised $4.25 million across 3 funding rounds from investors including IndieBio and LongeVC. Melio offers products and services including Melio Diagnostic Platform.
- Headquarter Santa Clara, United States
- Founders Shelley Lawrence, Stephanie Fraley, Mridu Sinha
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Melio, Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$4.25 M (USD)
in 3 rounds
-
Latest Funding Round
$4 M (USD), Series A
Jun 28, 2024
-
Investors
IndieBio
& 1 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Melio
Melio offers a comprehensive portfolio of products and services, including Melio Diagnostic Platform.
Bloodborne pathogen testing is delivered rapidly and accurately.
People of Melio
Unlock access to complete
Unlock access to complete
Funding Insights of Melio
Melio has successfully raised a total of $4.25M across 3 strategic funding rounds. The most recent funding activity was a Series A round of $4 million completed in June 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Melio
Melio has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include IndieBio and LongeVC.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Biotech startups are accelerated through IndieBio's focused programs.
|
Locked | Locked | Locked | |
|
LongeVC is focused on venture capital investments in biotech.
|
Locked | Locked | Locked |
Investor details for Melio
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Melio
Investment portfolio details for Melio
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Melio
Detailed financials for Melio
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Melio Comparisons
Peer comparison for Melio
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Melio
Detailed competitors of Melio
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Melio
Complete news archive for Melio
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Melio
Melio was founded in 2018 and raised its 1st funding round 4 years after it was founded.
Melio is headquartered in Santa Clara, United States. It is registered at Santa Clara, California, United States.
Mridu Sinha is the current CEO of Melio. They have also founded this company.
Melio is a funded company, having raised a total of $4.25M across 3 funding rounds to date.
A culture-free, rapid, and comprehensive blood testing platform is developed by Melio to identify pathogens in hours instead of days. Focus is placed on critical applications such as newborn care in NICUs, where timely diagnosis is essential. Advanced systems engineering, microfluidics, and machine learning are integrated to ensure faster and precise treatments. The technology is designed to adapt and detect newly emerging pathogens, expanding its diagnostic database. Solutions are aimed at addressing global challenges like antibiotic resistance within the healthcare sector.
Melio offers Melio Diagnostic Platform.
Melio has 2 investors. Key investors include IndieBio, and LongeVC.